Alzheimer's Disease Neuroimaging Initiative: Two decades of pioneering Alzheimer's disease research and future directions.
作者信息
Okonkwo Ozioma C, Rivera-Mindt Monica, Weiner Michael W
机构信息
Wisconsin Alzheimer's Disease Research Center and Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Department of Psychology, Latin American and Latino Studies Institute, African and African American Studies, Fordham University, New York, New York, USA.
出版信息
Alzheimers Dement. 2025 Jan;21(1):e14186. doi: 10.1002/alz.14186. Epub 2025 Jan 6.
Abstract
摘要
相似文献
1
Alzheimer's Disease Neuroimaging Initiative: Two decades of pioneering Alzheimer's disease research and future directions.阿尔茨海默病神经影像学计划：二十年开创性阿尔茨海默病研究及未来方向
Alzheimers Dement. 2025 Jan;21(1):e14186. doi: 10.1002/alz.14186. Epub 2025 Jan 6.
2
Argentina-Alzheimer's Disease Neuroimaging Initiative: pioneering Alzheimer's Research in Latin America and its Implications for Regional Advancement.阿根廷-阿尔茨海默病神经影像学倡议：拉丁美洲开创性的阿尔茨海默病研究及其对区域发展的影响。
Alzheimers Dement. 2024 Nov;20(11):8153-8161. doi: 10.1002/alz.14285. Epub 2024 Oct 6.
3
Maximizing the Alzheimer's Disease Neuroimaging Initiative II.最大化阿尔茨海默病神经影像学计划II
Alzheimers Dement. 2009 May;5(3):271-5. doi: 10.1016/j.jalz.2009.02.005. Epub 2009 Apr 11.
4
Overview of Alzheimer's Disease Neuroimaging Initiative and future clinical trials.阿尔茨海默病神经影像学计划概述及未来临床试验
Alzheimers Dement. 2025 Jan;21(1):e14321. doi: 10.1002/alz.14321. Epub 2024 Dec 22.
5
The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB).阿尔茨海默病神经影像学倡议及私人合作伙伴科学理事会的作用和贡献。
Alzheimers Dement. 2024 Jan;20(1):695-708. doi: 10.1002/alz.13483. Epub 2023 Sep 29.
6
The role of the Alzheimer's Association in the genesis of Alzheimer's Disease Neuroimaging Initiative.阿尔茨海默病神经影像学倡议中阿尔茨海默病协会的作用。
Alzheimers Dement. 2024 Nov;20(11):8183-8187. doi: 10.1002/alz.14228. Epub 2024 Sep 6.
7
The impact of the Alzheimer's Disease Neuroimaging Initiative 2: What role do public-private partnerships have in pushing the boundaries of clinical and basic science research on Alzheimer's disease?阿尔茨海默病神经影像倡议2的影响：公私合作在推动阿尔茨海默病临床和基础科学研究边界方面发挥着什么作用？
Alzheimers Dement. 2015 Jul;11(7):860-4. doi: 10.1016/j.jalz.2015.05.006.
8
A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative.阿尔茨海默病神经影像学倡议中对大脑结构成像的关注。
Biol Psychiatry. 2014 Apr 1;75(7):527-33. doi: 10.1016/j.biopsych.2013.11.020. Epub 2013 Nov 28.
9
The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022.阿尔茨海默病神经影像学倡议在阿尔茨海默病治疗时代：对 2021 年至 2022 年 ADNI 研究的回顾。
Alzheimers Dement. 2024 Jan;20(1):652-694. doi: 10.1002/alz.13449. Epub 2023 Sep 12.
10
Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative.血清钙水平降低可能与轻度认知障碍向早期阿尔茨海默病转化有关：日本阿尔茨海默病神经影像学倡议研究。
J Alzheimers Dis. 2019;68(2):777-788. doi: 10.3233/JAD-181115.
引用本文的文献
1
Spotlight on Alzheimer's disease and related dementias research in East Asia.聚焦东亚地区的阿尔茨海默病及相关痴呆症研究。
Alzheimers Dement. 2025 Jul;21(7):e70479. doi: 10.1002/alz.70479.
本文引用的文献
1
White matter integrity is associated with cognition and amyloid burden in older adult Koreans along the Alzheimer's disease continuum.白质完整性与认知功能和淀粉样蛋白负荷有关在老年韩国人沿着阿尔茨海默病连续体。
Alzheimers Res Ther. 2023 Dec 16;15(1):218. doi: 10.1186/s13195-023-01369-5.
2
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.两项早期阿尔茨海默病甘特纳单抗的 3 期临床试验。
N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430.
3
Trial of Solanezumab in Preclinical Alzheimer's Disease.在临床前阿尔茨海默病中进行的 Solanezumab 试验。
N Engl J Med. 2023 Sep 21;389(12):1096-1107. doi: 10.1056/NEJMoa2305032. Epub 2023 Jul 17.
4
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
5
Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials.评估 Crenezumab 与安慰剂在早期阿尔茨海默病成人患者中的安全性和疗效：两项 3 期随机安慰剂对照试验。
JAMA Neurol. 2022 Nov 1;79(11):1113-1121. doi: 10.1001/jamaneurol.2022.2909.
6
Optimal anti-amyloid-beta therapy for Alzheimer's disease via a personalized mathematical model.通过个性化数学模型优化阿尔茨海默病的抗β淀粉样蛋白治疗。
PLoS Comput Biol. 2022 Sep 2;18(9):e1010481. doi: 10.1371/journal.pcbi.1010481. eCollection 2022 Sep.
7
The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease.AHEAD 3-45 研究：阿尔茨海默病预防试验设计。
Alzheimers Dement. 2023 Apr;19(4):1227-1233. doi: 10.1002/alz.12748. Epub 2022 Aug 15.
8
Using imputation to provide harmonized longitudinal measures of cognition across AIBL and ADNI.使用插补法为 AIBL 和 ADNI 提供认知的协调纵向测量。
Sci Rep. 2021 Dec 10;11(1):23788. doi: 10.1038/s41598-021-02827-6.
9
The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology.纵向早发性阿尔茨海默病研究（LEADS）：框架与方法。
Alzheimers Dement. 2021 Dec;17(12):2043-2055. doi: 10.1002/alz.12350. Epub 2021 May 21.
10
Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease.随机试验：维鲁贝司他治疗前驱阿尔茨海默病。
N Engl J Med. 2019 Apr 11;380(15):1408-1420. doi: 10.1056/NEJMoa1812840.
Zotero 插件